Dabigatran vs warfarin: Less bleeding?

November 2009
Internal Medicine Alert;11/17/2009 Supplement, p21
The article reports on the results of a study regarding the effective use of dabigatran (DAB) and warfarin (WRF) in the reduction of atrial fibrilation (AF) risk factors.


Related Articles

  • Subclinical atrial fibrillation: how hard should we look? Wachter, Rolf; Stahrenberg, Raoul; Gröschel, Klaus // Heart;Feb2013, Vol. 99 Issue 3, p151 

    The authors discuss the risk factors associated with atrial fibrillation (AF). According to Framingham Heart Study, atrial fibrillation enhances the probability of stroke by a factor of five in non-rheumatic AF and by a factor of 17 in rheumatic AF. They also discuss the data released by the...

  • Effect of Race/Ethnicity on the Efficacy of Warfarin: Potential Implications for Prevention of Stroke in Patients with Atrial Fibrillation. Shen, Albert Yuh-Jer; Chen, Wansu; Yao, Janis F; Brar, Somjot S; Wang, Xunzhang; Go, Alan S // CNS Drugs;2008, Vol. 22 Issue 10, p815 

    Atrial fibrillation (AF) is the most common sustained arrhythmia seen in clinical practice. It affects approximately 6% of persons over 65 years of age and is independently associated with a 4- to 5-fold higher risk of ischaemic stroke and a 2-fold higher risk of death. Randomized controlled...

  • New Blood Thinners Make Life Easier for Many.  // Heart Advisor;Jan2015, Vol. 18 Issue 1, p6 

    The article discusses the benefits of blood thinners like warfarin or a novel oral anti-coagulant (NOAC) to patients at risk with atrial fibrillation. It explores the advantages of NOACs over warfarin, including their effectiveness, possible risks, and complications. Cleveland Clinic...

  • Factor Xa Inhibitors vs Warfarin for Preventing Stroke and Thromboembolism in Patients With Atrial Fibrillation. Bruins Slot, Karsten M. H.; Berge, Eivind // JAMA: Journal of the American Medical Association;3/19/2014, Vol. 311 Issue 11, p1150 

    The article discusses the use of factor XA inhibitors as an alternative for preventing strokes or other systemic embolic events in patients with atrial fibrillation. Topics discussed include the primary outcome of nine trials focused on treatment with a factor Xa inhibitor that revealed an...

  • Treating Atrial Fibrillation. Wang, Debbie; Conover, Damien // Morningstar StockInvestor;11/15/2009, Vol. 9 Issue 5, p26 

    The article presents the author's views on the aspects and risks of atrial fibrillation that can potentially cause blood clot and lead to stroke. The author muses on the decisions of physicians to medicate patients on anticoagulation therapy with the drug Warfarin which brings bleeding risks....

  • Risk stratification schemes, anticoagulation use and outcomes: the risk--treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation. Sandhu, Roopinder K.; Bakal, Jeffrey A.; Ezekowitz, Justin A.; McAlister, Finlay A. // Heart;Dec2011, Vol. 97 Issue 24, p2046 

    Objective To examine whether warfarin use and outcomes differ across CHADS2 and CHA2DS2-VASc risk strata for non-valvular atrial fibrillation (NVAF). Design Population-based cohort study using linked administrative databases in Alberta, Canada. Setting Inpatient and outpatient. Patients 42 834...

  • Clinical utility of dabigatran in United Arab Emirates. Shehab, Abdulla; Elnour, Asim A.; Sadik, Adel; Abu Mandil, Mahmoud; AlShamsi, Ali; Al Suwaidi, Aesha; Bhagavathula, AkshayaSrikanth; Erkekoglu, Pinar; Hamad, Farah; Al Nuaimi, Saif K. // Saudi Medical Journal;Nov2015, Vol. 36 Issue 11, p1290 

    Objectives: To provide early data regarding clinical utility of dabigatran in Al-Ain, United Arab Emirates (UAE). Methods: This was an ethics approved retrospective cross sectional study. We retrieved a total of 76 patients who were using dabigatran from September to December 2014 in the...

  • Atrial fibrillation increases risk of stroke mortality.  // Geriatrics;May97, Vol. 52 Issue 5, p100 

    Presents an abstract of the article `Atrial Fibrillation and Stroke: Mortality and Causes of Death After the First Acute Ischemic Stroke,' by MM Kaarisalo, P. Immonen-Raiha, et al from the `Stroke' dated February 1997.

  • QUICK STUDIES. Hearts Aflutter.  // Nutrition Action Health Letter;Sep2010, Vol. 37 Issue 7, p9 

    The article discusses research being done on the prevalence of atrial fibrillation among obese people which references studies published in the 2010 issues of the "Journal of the American College Cardiology" and the "American Journal of Clinical Nutrition."


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics